Grifols Partners With BARDA For Testing Ocular Immunoglobulin Eye Drops As Treatment For Sulfur Mustard-Induced Eye Injury
Grifols Partners With BARDA For Testing Ocular Immunoglobulin Eye Drops As Treatment For Sulfur Mustard-Induced Eye Injury
基立福與BARDA合作,測試注射用免疫球蛋白眼藥水作爲硫芥引起的眼部損傷的治療
Success Could Lead To FDA Approval For One Of The First Treatments For Chemical Warfare Ocular Damage, Phase 2 Trial For Dry Eye Disease Planned For 2025
成功可能導致FDA批准首個化學戰眼損傷治療之一,2025年計劃進行乾眼病二期試驗
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。